- 全部删除
您的购物车当前为空
GSK-A1 是 III 型磷脂酰肌醇 4-激酶 PI4KA 选择性抑制剂,pIC50为 8.5-9.8,抑制 PtdIns(4,5)P2 再合成,IC50约为 3 nM。GSK-A1有效降低 PtdIns(4)P 的水平,而对 PtdIns(4,5)P2 没影响。GSK-A1在抗丙型肝炎病毒方面有研究的潜力。


为众多的药物研发团队赋能,
让新药发现更简单!
GSK-A1 是 III 型磷脂酰肌醇 4-激酶 PI4KA 选择性抑制剂,pIC50为 8.5-9.8,抑制 PtdIns(4,5)P2 再合成,IC50约为 3 nM。GSK-A1有效降低 PtdIns(4)P 的水平,而对 PtdIns(4,5)P2 没影响。GSK-A1在抗丙型肝炎病毒方面有研究的潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 660 | In stock | |
| 5 mg | ¥ 1,320 | In stock | |
| 10 mg | ¥ 1,860 | In stock | |
| 25 mg | ¥ 3,360 | In stock | |
| 50 mg | ¥ 4,780 | In stock | |
| 100 mg | ¥ 6,660 | In stock | |
| 200 mg | ¥ 8,970 | In stock |
GSK-A1 相关产品
| 产品描述 | GSK-A1 is a specific inhibitor of PI4KA, also inhibited calcium-driven PRL secretion without affecting calcium signaling and Prl expression. GSK-A1 has anti-hepatitis C virus (HCV) potential. |
| 靶点活性 | PI4K2A:<5 (pIC50), PI4KA:8.5-9.8 (pIC50), PI4K2B:<5 (pIC50), PI4KB:7.2-7.7 (pIC50) |
| 体外活性 | GSK-A1 is a selective?type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα)?inhibitor with a?pIC50?of 8.5-9.8[3]. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2[3]. |
| 分子量 | 574.63 |
| 分子式 | C29H27FN6O4S |
| CAS No. | 1416334-69-4 |
| Smiles | COc1ncc(cc1S(=O)(=O)Nc1ccccc1F)-c1ccc2nc(N)n(-c3ccc(cc3)N3CCOCC3)c2c1 |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | DMSO: 2.3 mg/mL (4 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
DMSO
| |||||||||||
评论内容